J Clin Microbiol. 1993 October; 31(10): 2589-2593
Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients.
E H Bingen,
M Weber,
J Derelle,
N Brahimi,
N Y Lambert-Zechovsky,
M Vidailhet,
J Navarro and
J Elion
Laboratoire de Microbiologie, Hôpital Robert Debré, Paris, France.
ABSTRACT
We used DNA fingerprinting by the arbitrarily primed polymerase chain reaction (AP-PCR) technique for an epidemiological investigation of 23 Pseudomonas cepacia isolates obtained from 11 cystic fibrosis (CF) patients attending our CF center. This approach was compared with ribotyping, pulsed-field gel electrophoresis (PFGE), and conventional phenotypic typing. AP-PCR and ribotyping were identical in resolving power, since the two methods generated four different profiles and identified the same group of strains. Six patients on the one hand and four on the other harbored strains of the same genotype, thus raising the possibility of either patient-to-patient transmission or acquisition from a common hospital environmental source. PFGE results were in good agreement with those of the other two methods, but PFGE seems more discriminative since it generated a fifth profile for a single strain in a group of four. Our results show in vivo stability for the three methods during a period extending from 3 to 41 months. These genotypic techniques are particularly promising for clinical laboratories to help to clarify the epidemiology of P. cepacia in CF patients. The AP-PCR method constitutes an easier alternative to the well-established ribotyping method. AP-PCR provides the quickest results with minimal technical complexity. However, our results suggest that it is less discriminative than the labor-intensive PFGE method.
J Clin Microbiol. 1993 October; 31(10): 2589-2593
This article has been cited by other articles:
-
Brisse, S., Cordevant, C., Vandamme, P., Bidet, P., Loukil, C., Chabanon, G., Lange, M., Bingen, E.
(2004). Species Distribution and Ribotype Diversity of Burkholderia cepacia Complex Isolates from French Patients with Cystic Fibrosis. J. Clin. Microbiol.
42: 4824-4827
[Abstract]
[Full Text]
-
Souza, A. V., Moreira, C. R., Pasternak, J., Hirata, M. d. L., Saltini, D. A., Caetano, V. C., Ciosak, S., Azevedo, F. M., Severino, P., Vandamme, P., Magalhaes, V. D.
(2004). Characterizing uncommon Burkholderia cepacia complex isolates from an outbreak in a haemodialysis unit. J Med Microbiol
53: 999-1005
[Abstract]
[Full Text]
-
Coenye, T., Spilker, T., Martin, A., LiPuma, J. J.
(2002). Comparative Assessment of Genotyping Methods for Epidemiologic Study of Burkholderia cepacia Genomovar III. J. Clin. Microbiol.
40: 3300-3307
[Abstract]
[Full Text]
-
Henry, D. A., Mahenthiralingam, E., Vandamme, P., Coenye, T., Speert, D. P.
(2001). Phenotypic Methods for Determining Genomovar Status of the Burkholderia cepacia Complex. J. Clin. Microbiol.
39: 1073-1078
[Abstract]
[Full Text]
-
Marín, M., García de Viedma, D., Martín-Rabadán, P., Rodríguez-Créixems, M., Bouza, E.
(2000). Infection of Hickman Catheter by Pseudomonas (formerly Flavimonas) oryzihabitans Traced to a Synthetic Bath Sponge. J. Clin. Microbiol.
38: 4577-4579
[Abstract]
[Full Text]
-
BECKER, K., BADEHORN, D., DEIWICK, S., PETERS, G., FEGELER, W.
(2000). Molecular genotyping of Candida species with special respect to Candida (Torulopsis) glabrata strains by arbitrarily primed PCR. J Med Microbiol
49: 575-581
[Abstract]
[Full Text]
-
Okazaki, M., Watanabe, T., Morita, K., Higurashi, Y., Araki, K., Shukuya, N., Baba, S., Watanabe, N., Egami, T., Furuya, N., Kanamori, M., Shimazaki, S., Uchimura, H.
(1999). Molecular Epidemiological Investigation Using a Randomly Amplified Polymorphic DNA Assay of Burkholderia cepacia Isolates from Nosocomial Outbreaks. J. Clin. Microbiol.
37: 3809-3814
[Abstract]
[Full Text]
-
Bonacorsi, S., Fitoussi, F., Lhopital, S., Bingen, E.
(1999). Comparative In Vitro Activities of Meropenem, Imipenem, Temocillin, Piperacillin, and Ceftazidime in Combination with Tobramycin, Rifampin, or Ciprofloxacin against Burkholderia cepacia Isolates from Patients with Cystic Fibrosis. Antimicrob. Agents Chemother.
43: 213-217
[Abstract]
[Full Text]
-
Steinbach, S., Sun, L., Jiang, R.-Z., Flume, P., Gilligan, P., Egan, T. M., Goldstein, R.
(1994). Transmissibility of Pseudomonas cepacia Infection in Clinic Patients and Lung-Transplant Recipients with Cystic Fibrosis. NEJM
331: 981-987
[Abstract]
[Full Text]
Copyright © 1993 by the American Society for Microbiology. All rights reserved.